Key result
Positive affect is linked to lower five-year HbA1c in T2D, especially under high stress.
Why the study?
While affect is linked to diabetes outcomes, the specific role of positive affect in HbA1c and whether this relation is moderated by stress remains unclear.
Does positive affect prospectively predict lower HbA1c levels over time in adults recently diagnosed with type 2 diabetes?
Cohort (n=123)
No
Does positive affect prospectively predict lower HbA1c levels over time in adults recently diagnosed with type 2 diabetes?
Positive affect prospectively predicts lower HbA1c over 5 years in adults with type 2 diabetes, particularly buffering those experiencing high levels of stress.
Hypothesis-generating for positive affect as stress buffer in T2D; leaves open whether interventions improve HbA1c.
While affect is linked to a number of diabetes outcomes, the specific role of positive affect (PA) in HbA1c remains unclear. The present study examined whether PA prospectively predicted lower HbA1c among adults with type 2 diabetes and whether this relation was moderated by stress. Participants were 123 adults (44.7% female; 60.2% White, 39.8% Black) recently diagnosed with type 2 diabetes. Perceived stress, diabetes-specific distress, and PA were assessed at baseline; HbA1c was assessed at baseline (T1), six months (T2), and five years (T3). PA was cross-sectionally associated with lower HbA1c at T1 and prospectively predicted lower HbA1c at T3. PA interacted with both measures of T1 stress to predict T1 HbA1c, and PA interacted with T3 perceived stress to predict T3 HbA1c. Interactions were consistent with stress buffering. Sensitivity analyses attentuated findings, but robust evidence remained for PA as a protective factor for blood glucose five years later and for a stress-buffering effect of PA on diabetes-specific distress. Findings suggest PA may be a clinically useful indicator among adults with type 2 diabetes and may be particularly important for those experiencing the greatest stress from their disease.
No takes yet. Share an insight, caveat, or question.
Horner et al. (2023) conducted a cohort in Type 2 diabetes (n=123). Positive affect was evaluated on HbA1c at 5 years (β -0.36, 95% CI -0.61, -0.16). Baseline positive affect prospectively predicted lower HbA1c five years later (β -0.36) among adults with type 2 diabetes, and this protective effect was strongest for those experiencing high stress.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: